Aspen Pharmacare - 16 Year Stock Price History | APNHY

Historical daily share price chart and data for Aspen Pharmacare since 2009 adjusted for splits and dividends. The latest closing stock price for Aspen Pharmacare as of July 18, 2025 is 6.40.
  • The all-time high Aspen Pharmacare stock closing price was 34.48 on January 26, 2015.
  • The Aspen Pharmacare 52-week high stock price is 13.85, which is 116.4% above the current share price.
  • The Aspen Pharmacare 52-week low stock price is 5.76, which is 10% below the current share price.
  • The average Aspen Pharmacare stock price for the last 52 weeks is 9.21.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Aspen Pharmacare Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 7.9871 8.2600 9.9400 5.9800 6.4000 -22.52%
2024 11.0480 10.6256 13.5799 8.2600 8.2600 -24.32%
2023 9.1258 7.7451 10.9149 7.4336 10.9149 41.67%
2022 9.7285 12.9897 13.9226 6.9912 7.7047 -41.68%
2021 11.5754 7.9395 17.0782 7.8233 13.2114 66.56%
2020 6.9953 8.0873 8.3122 4.6542 7.9321 0.11%
2019 6.9379 8.4739 10.5501 3.9386 7.9237 -9.03%
2018 16.1420 20.0100 21.7442 8.2573 8.7099 -57.40%
2017 19.7191 18.4829 22.1045 17.9145 20.4479 9.11%
2016 19.4408 16.6538 25.6762 14.0792 18.7405 4.64%
2015 25.7058 30.8872 34.4766 16.9785 17.9102 -42.43%
2014 25.3742 22.6894 33.5685 19.2498 31.1080 34.76%
2013 20.1720 16.3867 24.8511 16.0117 23.0844 33.44%
2012 14.0250 11.0903 17.2996 11.0903 17.2996 72.18%
2011 9.8843 10.3755 10.4307 9.3600 10.0474 15.59%
2010 9.3574 9.5636 9.9516 8.6924 8.6924 64.97%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $2.392B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $18.707B 6.68
Dr Reddy's Laboratories (RDY) India $12.148B 22.05
BridgeBio Pharma (BBIO) United States $8.716B 0.00
Bausch Health Cos (BHC) Canada $2.339B 1.69
Supernus Pharmaceuticals (SUPN) United States $1.861B 15.10
Amphastar Pharmaceuticals (AMPH) United States $0.999B 6.71
Personalis (PSNL) United States $0.548B 0.00
Taysha Gene Therapies (TSHA) United States $0.543B 0.00
Assembly Biosciences (ASMB) United States $0.139B 0.00
Sol-Gel Technologies (SLGL) Israel $0.023B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00